Study on the application of zoledronic acid in the treatment of osteoporotic vertebral compression fractures with PKP
10.3969/j.issn.1005-1678.2017.09.099
- VernacularTitle:唑来膦酸治疗骨质疏松性椎体压缩骨折PKP术后应用研究
- Author:
Yang LIU
;
Hui LI
;
Xin HE
;
Houkun LI
;
Jianan ZHANG
;
Bin ZHANG
;
Tao SONG
;
Dingjun HAO
- Keywords:
osteoporosis;
vertebral compression fracture;
PKP holds the operation;
azole to phosphonic acid
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(9):226-227,229
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the application effect of zoledronic acid on PKP after osteoporotic vertebral compression fractures. Methods According to different treatment methods, 80 cases of patients from January 2015 to January 2017 in Xi'an City, Hong hui Red Cross hospital diagnosis and treatment of osteoporotic vertebral compression fractures parallel PKP were divided into two groups. The patients in the control group were not treated with zoledronic acid, and the patients in the observation group were treated with zoledronic acid.The treatment effect and adverse reaction rate were compared between two groups. Results The treatment effect of the observation group was better than that of the control group, and the improvement of the clinical symptoms of the observation group was better than that of the control group, and the incidence of adverse reactions was lower than that of the control group, the difference was statistically significant (P<0.05). Conclusion The effect of zoledronic acid treatment on osteoporotic vertebral compression fractures after PKP is remarkable, which can effectively improve the patients' clinical symptoms, less adverse reactions, is widely used in clinical osteoporotic vertebral compression fractures after PKP holds.
